Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ryan J, Mattison"'
Autor:
Hongtao Liu, Elad Sharon, Theodore G. Karrison, Yuanyuan Zha, Noreen Fulton, Howard Streicher, Kendra Sweet, George Yaghmour, Jane Jijun Liu, Brian A. Jonas, Aaron D. Schimmer, Steven Grant, Amer M. Zeidan, Gerhard C. Hildebrandt, Christopher S. Hourigan, Christopher H. Lowrey, Ryan J. Mattison, Neil Palmisiano, Amandeep Salhotra, Dimitrios Tzachanis, Maria R. Baer, Tara L. Lin, Prapti Patel, Helen Chen, Walter M. Stadler, Olatoyosi Odenike, Richard A. Larson, Thomas F. Gajewski, Wendy Stock
Publikováno v:
Blood. 140:1716-1719
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04fb86e72e5c0992e5a0b3818bc47b3a
https://doi.org/10.1182/blood-2022-157326
https://doi.org/10.1182/blood-2022-157326
Autor:
Michael Byrne, Ryan J Mattison, Rachel Sara Bercovitz, Richard Lottenberg, Suely Meireles Rezende, Roy L. Silverstein, Deirdra R Terrell, Robert Kunkle, Deion Smith, Catherine M. Bollard, Sandra L Haberichter, Jennifer Lin Holter-Chakrabarty, Menaka Pai, Matthew C Cheung, Adam Cuker, Matthew Seftel, Benjamin Djulbegovic
Publikováno v:
Blood Advances.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d9b61835bdda9d8da4db8531451600
https://doi.org/10.1182/bloodadvances.2023010039
https://doi.org/10.1182/bloodadvances.2023010039
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Combining venetoclax, a selective BCL2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL2 inhibitor, may allow targeting of both BCL2 and BCL-XL without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preliminary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45bfde002b935bce0e2049afbee2a4b
https://doi.org/10.1158/2159-8290.c.6549358.v1
https://doi.org/10.1158/2159-8290.c.6549358.v1
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a7a73d874845837c5236e29615a265
https://doi.org/10.1158/2159-8290.22540348.v1
https://doi.org/10.1158/2159-8290.22540348.v1
Autor:
Vikas Gupta, Abdulraheem Yacoub, Srdan Verstovsek, Ruben Mesa, Claire Harrison, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, H. Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Vinod Parameswaran, Patricia Martin-Regueira, Christopher Hernandez, Jia Wang, Moshe Talpaz
Publikováno v:
Blood. 140:3935-3937
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f6ee2c21012cb1bef12aa2cf2250df
https://doi.org/10.1182/blood-2022-156669
https://doi.org/10.1182/blood-2022-156669
Autor:
Emma E Williams, Danielle McQuinn, Lauren G. Banaszak, Cameron Ninos, Ryan J. Mattison, Zhubin Gahvari, Aric C. Hall, Michael J Fallon, Kalyan VG Nadiminti
Publikováno v:
Blood. 140:6099-6101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8fbc344cbb3675b91eefdbe42c6e5fa
https://doi.org/10.1182/blood-2022-169577
https://doi.org/10.1182/blood-2022-169577
Autor:
Grace C. Blitzer, Nicole M. Rogus-Pulia, Ryan J. Mattison, Tomy Varghese, Olga Ganz, Richard Chappell, Jacques Galipeau, Kimberly A. McDowell, Ross O. Meyers, Tiffany A. Glazer, Randall J. Kimple
Publikováno v:
Cytotherapy. 24:534-543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e38f83e71cf17f75bf54869c89d3129e
https://doi.org/10.1016/j.jcyt.2021.11.003
https://doi.org/10.1016/j.jcyt.2021.11.003
Autor:
Patricia Aoun, Suzanne L. Kirby, Stephanie A. Massaro, Daniel J. DeAngelo, Shira Dinner, Jordan Gauthier, Aaron C Logan, Lori J. Maness, Jeffrey E. Rubnitz, Patrick A. Brown, Michaela Liedtke, Madhuri Vusirikala, Amanda Przespolewski, Beth Lynn, Geoffrey L. Uy, Nitin Jain, Mallory Campbell, William A. May, Ryan J. Mattison, Bijal D. Shah, Amir T. Fathi, Mark R. Litzow, Michael Boyer, Anjali S. Advani, Sravanti Rangaraju, Ryan A. Berardi, Olalekan O. Oluwole, Jae H. Park, Matthew J. Wieduwilt, Patrick W. Burke, Deborah A. Freedman-Cass, Selina M. Luger
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:1079-1109
The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606d5077a0bd12db89986f037a313a04
https://doi.org/10.6004/jnccn.2021.0042
https://doi.org/10.6004/jnccn.2021.0042
Autor:
Diego Hernando, Ruiyang Zhao, Qing Yuan, Mounes Aliyari Ghasabeh, Stefan Ruschke, Xinran Miao, Dimitrios C. Karampinos, Lu Mao, David T. Harris, Ryan J. Mattison, Michael R. Jeng, Ivan Pedrosa, Ihab R. Kamel, Shreyas Vasanawala, Takeshi Yokoo, Scott B. Reeder
Publikováno v:
Radiology.
Background MRI is a standard of care tool to measure liver iron concentration (LIC). Compared with regulatory-approved R2 MRI, R2* MRI has superior speed and is available in most MRI scanners; however, the cross-vendor reproducibility of R2*-based LI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441e98b38e30cfa10757261bdaa450cb
https://pubmed.ncbi.nlm.nih.gov/36194113
https://pubmed.ncbi.nlm.nih.gov/36194113
Autor:
Emily Curran, Amy Wang, Michaela Liedtke, Aniko Szabo, Ryan J. Mattison, Madelyn Burkart, Caitlin Siebenaller, Ehab Atallah, Anand Patel, Jay Yang, Muhammad Ali Khan, Martha Wadleigh, Rory M. Shallis, Shukaib Arslan, Suresh Kumar Balasubramanian, Mehrdad Hefazi, Shira Dinner, Nikolai A. Podoltsev, Mark R. Litzow, Anjali S. Advani, Talha Badar, Ilana R. Yurkiewicz, Eric Kuo, Ibrahim Aldoss
Publikováno v:
Cancer. 127:1039-1048
Background The availability of novel agents (NAs), including blinatumomab and inotuzumab ozogamicin (InO), has improved the outcomes of patients with relapsed/refractory (RR) B-cell acute lymphoblastic leukemia (ALL). Because of the relative effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034e483a41c5da48475562ac50111320
https://doi.org/10.1002/cncr.33340
https://doi.org/10.1002/cncr.33340